Purdue Pharma
Democratic Senators urge judge to reject Purdue Pharma’s proposal to pay CEO a bonus
September 22, 2020Manufacturing and Production OxyContin, Purdue, Purdue Pharma
Democratic US Senators are urging Judge Robert D. Drain to reject Purdue Pharma’s proposal to pay CEO and President Craig …
Judge overseeing Purdue Pharma bankruptcy approves $1.3 million bonus for CEO
January 27, 2020Sales and Marketing Election 2020, OxyContin, Purdue Pharma, US Presidential Race, fentanyl, opioid crisis
Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge. Judge Robert Drain said the company …
Sackler family withdrew $10 billion from Purdue Pharma while legal pressure mounted, audit shows
December 17, 2019Manufacturing and Production Oxy, OxyContin, Purdue Pharma, Sackler family, opioid, opioid crisis, sackler
An audit commissioned by Purdue Pharma, to help navigate its bankruptcy, indicates that members of the Sackler family withdrew $10.7 …
Purdue Pharma’s Richard Sackler ignored OxyContin addiction concerns, new emails show
December 3, 2019Manufacturing and Production, Sales and Marketing Opiod, Purdue Pharma, Richard Sackler, opiod crisis
A recently exposed 1997 email chain shows Dr Richard Sackler, member of the billionaire founding family of Purdue Pharma, knew …
Opioid drugmaker Purdue Pharma files for bankruptcy
September 16, 2019Sales and Marketing OxyContin, Purdue Pharma
In the face of thousands of lawsuits in its role in the opioid addiction crisis, Purdue Pharma announced yesterday that …
Sacklers could give up Purdue Pharma and settle 2,000 lawsuits for $10-12 billion, proposal says
August 28, 2019Research and Development OxyContin, Purdue Pharma, Sackler family, opioid crisis, opioids, pharma
The Sackler family are offering to settle more than 2,000 opioid crisis lawsuits for between $10-12 billion, according to NBC. …
Louvre takes down all references to Purdue-owning Sackler family
July 17, 2019Medical Communications Art, Louvre, PR, Purdue Pharma, Sacklers, donations
The Louvre taken down references to the Sacklers, the billionaire owners of Purdue Pharma. The largest art gallery in the …
Sacklers file motion to throw lawsuit out of court
April 5, 2019Medical Communications Massachusetts, OxyContin, Purdue Pharma, opioid crisis, opioids, sackler
Members of the Sackler family have asked a judge to throw a lawsuit – filed by Massachusetts attorney general Maura …
Sacklers fraudulently transferred funds to dodge litigation, lawsuit says
March 29, 2019Medical Communications Litigation, New York, OxyContin, Purdue Pharma, Sackelr, opioids
New York state prosecutors have filed a lawsuit against members of the Sackler family, alleging the Purdue Pharma controllers fraudulently …
Purdue Pharma settle Oklahoma lawsuit for $270 million
March 26, 2019Research and Development Oklahoma, OxyContin, Purdue Pharma, opioid crisis, oxycodone
OxyContin drugmaker Purdue Pharma has agreed to pay nearly $270 million to the state of Oklahoma, in order to settle …
Tate art galleries will not accept donations from Sacklers
March 22, 2019Medical Communications OxyContin, Purdue Pharma, Sacklers, Tate, art galleries, opioid crisis
The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the …
Purdue Pharma vow not to profit from fast tracked opioid overdose antidote
March 18, 2019Sales and Marketing FDA, OxyContin, Purdue Pharma, nalmefene hydrochloride, opioids
The FDA has granted OxyContin drugmaker Purdue Pharma, fast track designation for opioid overdose antidote nalmefene hydrochloride (HCl) injection. However, …
OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say
March 4, 2019Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials
OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …
Eisai and Purdue reveal positive Phase 3 data in insomnia
February 7, 2019Research and Development Eisai, Purdue Pharma, insomnia, lemborexant, pharma
Partners Eisai and Purdue Pharma have lifted the curtain on Phase 3 clinical data on their jointly developed therapy lemborexant …
Purdue Pharma sought to expand into opioid addiction treatments while using McKinsey to counter “emotional messages”
January 31, 2019Business Services, Medical Communications Massachusetts, OxyContin, Purdue Pharma, US, USA, opioids
OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …
